No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA — Eli Lilly has announced that it will invest US$450 million in a North Carolina manufacturing plant to meet the rising demand for its diabetes drugs Mounjaro and Trulicity.…
Read More
USA — The US Food and Drug Administration (FDA) has approved a label update for Novo Nordisk’s oral semaglutide (Rybelsus) allowing the agent to be used as an initial treatment…
Read More
DENMARK —Novo Nordisk has expanded its collaboration with Amalgam Rx, a US-based company to support the commercialization of Dose Check, a digital insulin initiation and titration app. Dose Check digital…
Read More
USA — Eli Lilly and Co. has decided to end its joint project with Ypsomed to enter the US insulin pump market and instead focus on its diabetes offerings. In…
Read More
INDIA — Biocon has announced the signing of a semi-exclusive partnership agreement with Zentiva, a leading pharmaceutical company in Europe, for the commercialization of its vertically integrated, complex formulation, Liraglutide.…
Read More
EGYPT – Egypt, through the Minister of Health and Population, Khaled Abdel-Ghaffar, has announced the launch of a new high-capacity insulin production line by Egypt’s Medical Union Pharmaceutical Company (MUP).…
Read More
USA — TheU.S Food and Drug Administration (FDA) has designated Eli Lilly’s Rezvoglar as “interchangeable” with Sanofi’s Lantus, making it the second insulin biosimilar to receive the prestigious designation. Rezvoglar…
Read More
USA — The U.S. Food and Drug Administration (FDA) has approved the use of its drug teplizumab in those aged eight years and older, the first treatment aimed at delaying…
Read More
INDIA — Sawai Man Singh Hospital doctors have given a ray of hope to diabetes patients as they claimed that chances of reversal of diabetes are quite high. They claimed…
Read More
USA — Medtronic, a healthcare technology company, has launched a new infusion set called Medtronic Extended, which can be worn continuously for up to seven days in the United States.…
Read More